Document is current
Any future updates will be listed below
-
Authors
Brown, Libby
Vidal, Aldrin V. https://orcid.org/0000-0003-1539-1721
Dias, Ana Laura https://orcid.org/0000-0002-8933-0780
Rodrigues, Tiago https://orcid.org/0000-0002-1581-5654
Sigurdardottir, Anna https://orcid.org/0000-0002-5225-397X
Journeaux, Toby
O’Brien, Siobhan
Murray, Thomas V. https://orcid.org/0000-0003-3019-2739
Ravn, Peter
Papworth, Monika
Bernardes, Gonçalo J. L. https://orcid.org/0000-0001-6594-8917
-
Funding
Funding for this research was provided by:
RCUK | Biotechnology and Biological Sciences Research Council (10046039)
Deutsche Forschungsgemeinschaft (493006134)
- License Information
-
More Information
Article History
Received: 17 November 2023
Accepted: 13 August 2024
First Online: 24 August 2024
Competing interests
: L.B., S.O’B., A.S., T.V.M., P.R., and M.P. are or were formerly employed by AstraZeneca plc. All other authors declare no competing interests.
